Cargando…
The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injury
Valproic acid (VPA) is widely used as a major drug in the treatment of epilepsy. Despite the undisputed pharmacological importance and effectiveness of VPA, its potential hepatotoxicity is still a major concern. Being a simple fatty acid, the hepatotoxicity induced by VPA has long been considered to...
Autores principales: | Ma, Yiyi, Wang, Minglu, Guo, Shuaishuai, Li, Tong, Liu, Xiaodong, Zhao, Limei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681037/ https://www.ncbi.nlm.nih.gov/pubmed/36425583 http://dx.doi.org/10.3389/fphar.2022.1048728 |
Ejemplares similares
-
Lipidomic Profiling Reveals Disruption of Lipid Metabolism in Valproic Acid-Induced Hepatotoxicity
por: Xu, Shansen, et al.
Publicado: (2019) -
The potential antiepileptic activity of astaxanthin in epileptic rats treated with valproic acid
por: Ata Yaseen Abdulqader, Yussra, et al.
Publicado: (2021) -
Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
por: Chung, S., et al.
Publicado: (1997) -
Effects of Valproic Acid on Cerebral Nutrient Carriers' Expression in the Rat
por: Mann Brukner, Aniv, et al.
Publicado: (2018) -
Lipidomic characteristics and clinical findings of epileptic patients treated with valproic acid
por: Li, Rong, et al.
Publicado: (2019)